Back to Search
EDWARD GABRIELSON, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1770521569Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
MD210003124(DC)D30905(MD)
CMS Specialties
PrimaryPATHOLOGY
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1977
Research & Publications (20)
Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine.
PMID 15138709·Cancer Chemother Pharmacol·2004
8-other
Clinical and biological relevance of recently defined categories of pulmonary neoplasia.
PMID 12415684·Methods Mol Med·2003
6-review
Increased fatty acid synthase is a therapeutic target in mesothelioma.
PMID 11205903·Clin Cancer Res·2001
7-preclinical
Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.
PMID 19520915·Am J Respir Cell Mol Biol·2010
7-preclinical
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
PMID 19564528·J Clin Oncol·2009
4-observational
Chromosomal changes in aggressive breast cancers with basal-like features.
PMID 19602461·Cancer Genet Cytogenet·2009
8-other
Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma.
PMID 19124015·Exp Mol Pathol·2009
8-other
Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors.
PMID 18413838·Clin Cancer Res·2008
7-preclinical
DNA methylation markers and early recurrence in stage I lung cancer.
PMID 18337602·N Engl J Med·2008
8-other
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.
PMID 18829555·Cancer Res·2008
7-preclinical
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer.
PMID 18283316·Br J Cancer·2008
8-other
Cross-study validation and combined analysis of gene expression microarray data.
PMID 17873151·Biostatistics·2008
8-other
Selective inhibition of fatty acid synthase for lung cancer treatment.
PMID 18056164·Clin Cancer Res·2007
7-preclinical
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancer.
PMID 17404812·Pharm Res·2007
7-preclinical
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
PMID 17593079·Histopathology·2007
8-other
Coix seed extract, a commonly used treatment for cancer in China, inhibits NFkappaB and protein kinase C signaling.
PMID 18087221·Cancer Biol Ther·2007
7-preclinical
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
PMID 17020408·PLoS Med·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4940 EASTERN AVE
BALTIMORE, MD 21224 - Phone
- (410) 955-2660
Quick Facts
- NPI
- 1770521569
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile